Showing posts with label Clive James. Show all posts
Showing posts with label Clive James. Show all posts

Friday, May 27, 2016

ISAAA Brief 51 Launched in Beijing; Media Conferences Held in Six Countries

ISAAA has released the 20th Brief in its global status of commercialized biotech/GM crops in Beijing, China on April 13, 2016. Brief 51, 20th Anniversary (1996 to 2015) of the Global Commercialization of Biotech Crops and Biotech Crops Highlights in 2015, authored by ISAAA Founder and Emeritus Chair, Clive James.

Brief 51 companion documents include the Executive Summary, Top Ten Facts about Biotech Crops and a volume of Invitational Essays (Progress and Promise), which are designed to celebrate the 20th Anniversary of the commercialization of biotech crops during the twenty-year period, 1996 to 2015 as well as the 2015 highlights.

Year after year, ISAAA prepares the global status report and supports its free distribution to developing countries to provide information and knowledge to the scientific community and facilitate a more informed and transparent discussion regarding the potential role of biotech crops in contributing to global food, feed, fiber, and fuel security, and a more sustainable agriculture.

The 2015 Global Status Report documents the global database on the adoption and distribution of biotech crops in the world in 2015, when ~18 million farmers from 28 countries planted 179.7 million hectares of biotech crops. Below are summaries of the country launches held for the 2015 Global Status Report.

BEIJING, CHINA

Brief 51 was launched in the ISAAA Press Conference in China World Hotel Beijing on April 13, 2016, attended by 30 representatives of major media outlets (print, online, and TV broadcast). Dr. Paul S. Teng, ISAAA Chair, presented the Highlights of the Report prepared by Dr. James. ISAAA Global Coordinator Dr. Randy A. Hautea discussed the Overview of Biotech Crops in Asia with emphasis on biotech crop planting and regulatory milestones in India, China, Pakistan, Myanmar, Philippines, Australia, Bangladesh, and Vietnam, which has commercialized biotech maize for the first time in 2015.
Dr. Zhang Chun-Yi, Dr. Paul S. Teng, Dr. Randy A. Hautea, Mr. Hernan Viola, and Dr. Dafang Huang at the media seminar in Beijing.

Mr. Hernan Viola, the Agro-Industrial Attaché of the Embassy of Argentina in China, presented an overview of biotech crops and the benefits they generated in Argentina. Dr. Zhang Chun-Yi, Deputy Director General of the Biotechnology Research Institute, CAAS and Prof. Dafang Huang, patron of ISAAA, gave the opening and closing remarks, respectively.

A seminar was conducted on April 14 at the Library of the Chinese Academy of Sciences (CAS) where Dr. Gao Caixia of the Institute of Genetics and Biology, CAS, made a timely presentation on Genome Editing: Progress and Perspectives.  Mr. Mark Petry of the USDA FAS gave a presentation on Reconsideration of New Breeding Technology and Biotech Regulation in the US. Some 150 members of the academe, government regulators, industry, media, students and researchers attended the seminar which was co-organized by CAAS, the Chinese Academy of Agricultural Sciences, and the ISAAA China BIC.

HANOI, VIETNAM

Brief 51 was presented at a media seminar held at the Sofitel Plaza Hotel in Hanoi on April 15. The seminar was co-organized by the Agricultural Genetics Institute (AGI) led by Dr. Le Huy Ham. Drs. Teng and Hautea were joined by Dr. Mahaletchumy Arujanan, executive director of the Malaysian Biotechnology Information Center (MABIC), who presented the Overview of New Breeding Technologies and Current Status. Around 100 attendees composed of researchers, policy makers, regulators, industry representatives, and media practitioners attended the event, and received copies of Brief 51 materials that were distributed during the seminar.

JAKARTA, INDONESIA
Mr. Bhagirath Choudhary

The seminar in Jakarta was held in the Ministry of Agriculture on April 19. Dr. Arujanan presented the Highlights of Brief 51, and also made a presentation on new breeding technologies. Mr. Bhagirath Choudhary, director of the South Asia Biotechnology Center based in India presented the Overview of Biotech Crop Adoption in Asia. 

The event was co-organized by ISAAA and IndoBIC, with around 100 members of the academe, media practitioners, and policy makers, including regulators and industry representatives in attendance. Copies of Brief 51 materials were distributed at the close of the seminar.

BURKINA FASO

The ISAAA AfriCenter in collaboration with Africa Seed Trade Association (AFSTA) and the Association Nationale des Entreprises Semencières du Burkina Faso (ANES-BF), a local seed trade association, launched the Brief 51 in Burkina Faso on April 20, 2016. The event was attended by 40 participants that included seed traders, media representatives, government regulators, and scientists. Hon. Henri Koubizara, a member of the parliamentary commission on economic development, environment and climate change was the guest of honor. Dr. Margaret Karembu presented the ISAAA report highlighting the role of seed traders in the adoption and commercialization of GM crops. Local scientists and regulators shared the status of GM crop research and regulation in Burkina Faso, and the West Africa region at large.
Hon. Henri Koubizara and Dr. Margaret Karembu at the launch in Burkina Faso.

MANILA, PHILIPPINES

A media conference organized by ISAAA and SEARCA BIC for Philippine journalists and stakeholders was held at Acacia Hotel Manila on April 29. Dr. Teng presented the ISAAA report for 2015. Dr. Gour Pada Das, Country Coordinator of the Feed the Future Bangladesh, and Dr. ASM Mahbubur Rahman Khan, Chief Scientific Officer of Bangladesh Agricultural Research Institute (BARI), discussed the highlights of the Bt brinjal project and commercialization experience, respectively. Over 50 representatives from media, academe, research, and private companies attended the event.
Drs. G.P. Das and ASM Mahbubur Rahman Khan (center) at the Manila launch.

DHAKA, BANGLADESH

In Bangladesh, the Honorable Minister of Agriculture Matia Chowdhury inaugurated the seminar on 20th Anniversary of the Global Commercialization of Biotech Crops and Biotech Crop Highlights in 2015 at the Bangladesh Agricultural Research Council (BARC) in Dhaka, Bangladesh on May 12.
Hon. Minister for Agriculture Matia Chowdhury (center) at the Brief 51 launch in Dhaka.

Resource persons in the seminar included Drs. Hautea and Arujanan, and Mr. Choudhary. Dr. G.P. Das facilitated the seminar which was attended by agriculture officials and members of the scientific community in Bangladesh.  During the seminar, Minister Chowdhury emphasized the need for scientific innovations nd collaborations to improve food production and poverty alleviation in Bangladesh. She also stated that the government is pro-active in adopting biotech innovations for introducing improved varieties to their farmers. The seminar was jointly organized by BARI, BARC, and ISAAA.


More information about ISAAA Brief 51 20th Anniversary (1996 to 2015) of the Global Commercialization of Biotech Crops and Biotech Crops Highlights in 2015 are available at the ISAAA website: http://www.isaaa.org/resources/publications/briefs/51/default.asp. 

Brief 51 companion documents are available for download from the same link.

For more information about ISAAA, visit http://www.isaaa.org/, or follow ISAAA on Facebook (https://www.facebook.com/isaaa.org) and Twitter (https://twitter.com/isaaa_org). 

Friday, April 15, 2016

2015 Marks Two Billion Hectares of Biotech Crop Plantings

Farmers Reap >US$150 Billion from Advances in Biotech Crops over 20 Years

The International Service for the Acquisition of Agri-Biotech Applications (ISAAA) has released this week its annual report detailing the adoption of biotech crops, 20th Anniversary of the Global Commercialization of Biotech Crops (1996-2015) and Biotech Crop Highlights in 2015, showcasing the global increase in biotech hectarage from 1.7 million hectares in 1996 to 179.7 million hectares in 2015. This 100-fold increase in just 20 years makes biotechnology the fastest adopted crop technology in recent times, reflecting farmer satisfaction with biotech crops.


Since 1996, 2 billon hectares of arable land – a massive area more than twice the landmass of China, 
or the United States – have been planted with biotech crops. Additionally, it is estimated that farmers in up to 28 countries have reaped more than US$150 billion in benefits from biotech crops since 1996. This has helped alleviate poverty for up to 16.5 million small farmers and their families annually totaling about 65 million people, who are some of the poorest people in the world.

“More farmers are planting biotech crops in developing countries precisely because biotech crops are a rigorously-tested option for improving crop yields,” said Clive James, founder and emeritus chair of ISAAA, who has authored the ISAAA report for the past two decades. “Despite claims from opponents that biotechnology only benefits farmers in industrialized countries, the continued adoption of the technology in developing countries disproves that” James added.

For the fourth consecutive year, developing countries planted more biotech crops (14.5 million hectares) than industrialized countries. In 2015, Latin American, Asian and African farmers grew biotech crops on 54 percent of global biotech hectarage (97.1 million hectares of 179.7 million biotech hectares) and of the 28 countries that planted biotech crops, 20 were developing nations. Annually, up to 18 million farmers, 90 percent of whom were small, resource-poor growers in developing countries, benefited from planting biotech crops from 1996 to 2015.


“China is just one example of biotechnology’s benefits for farmers in developing countries. Between 1997 and 2014, biotech cotton varieties brought an estimated $17.5 billion worth of benefits to Chinese cotton farmers, and they realized $1.3 billion in 2014 alone,” explained ISAAA Global Coordinator, Randy Hautea.

Also in 2015, India became the leading cotton producer in the world with much of its growth attributed to biotech Bt cotton. India is the largest biotech cotton country in the world with 11.6 million hectares planted in 2015 by 7.7 million small farmers. In 2014 and 2015, an impressive 95 percent of India’s cotton crop was planted with biotech seed; China’s adoption in 2015 was 96 percent.


“Farmers, who are traditionally risk-averse, recognize the value of biotech crops, which offer benefits to farmers and consumers alike, including drought tolerance, insect and disease resistance, herbicide tolerance, and increased nutrition and food quality,” Hautea added. “Moreover, biotech crops contribute to more sustainable crop production systems that address concerns regarding climate change and global food security.”

Following a remarkable run of 19 years of consecutive growth from 1996 to 2014, with 12 years of double-digit growth, the global hectarage of biotech crops peaked at 181.5 million hectares in 2014, compared with 179.7 million hectares in 2015, equivalent to a net marginal decrease of 1 percent. This change is principally due to an overall decrease in total crop hectarage, associated with low prices for commodity crops in 2015. ISAAA anticipates that total crop hectarage will increase when crop prices improve. For example, Canada has projected that canola hectarage in 2016 will revert to the higher level of 2014. Other factors affecting biotech hectarage in 2015 include the devastating drought in South Africa, which led to a massive 23 percent decrease of 700,000 hectares in intended plantings in 2015. The drought in eastern and southern Africa in 2015/2016 puts up to 15 to 20 million poor people at risk for food insecurity and compels South Africa, usually a maize exporter, to rely on maize imports.


Additional highlights from ISAAA’s 2015 report include:
  • New biotech crops were approved and/or commercialized in several countries, including the United States, Brazil, Argentina, Canada and Myanmar.
  • The United States saw a number of firsts, including the commercialization of new products such as:
    • Innate™ Generation 1 potatoes, with lower levels of acrylamide, a potential carcinogen, and resistance to bruising. InnateTM Generation 2, approved in 2015, also has late blight resistance. It is noteworthy that the potato is the fourth most important food crop in the world.
    • Arctic® Apples that do not brown when sliced. 
    • The first non-transgenic genome-edited crop to be commercialized globally, SU Canola™, was planted in the United States. 
    • The first-time approval of a GM animal food product, GM salmon, for human consumption.
  • Biotech crops with multiple traits, often called “stacked traits,” were planted on 58.5 million hectares, representing 33 percent of all biotech hectares planted and a 14 percent year-over-year increase.
  • Vietnam planted a stacked-trait biotech Bt and herbicide-tolerant maize as its first biotech crop.
  • Biotech DroughtGard™ maize, first planted in the United States in 2013, increased 15-fold from 50,000 hectares in 2013 to 810,000 hectares reflecting high farmer acceptance. 
  • Sudan increased Bt cotton hectarage by 30 percent to 120,000 hectares, while various factors precluded a higher hectarage in Burkina Faso. 
  • Eight African countries field-tested, pro-poor, priority African crops, the penultimate step prior to approval.
Looking ahead to the future of biotechnology in agriculture, ISAAA has identified three key opportunities to realize continued growth in adoption of biotech crops, which are as follows:·
  • High rates of adoption (90 percent to 100 percent) in current major biotech markets leave little room for expansion. However, there is a significant potential in other “new” countries for selected products, such as biotech maize, which has a potential of approximately 100 million more hectares globally, 60 million hectares in Asia, of which 35 million is in China alone, plus 35 million hectares in Africa. 
  • More than 85 potential new products in the pipeline are now being field-tested; including a biotech drought tolerant maize from the WEMA project (Water Efficient Maize for Africa) expected to be released in Africa in 2017, Golden Rice in Asia, and fortified bananas and pest-resistant cowpea in Africa. 
  • CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) a new powerful genome editing technology has significant comparative advantages over conventional and GM crops in four domains: precision, speed, cost and regulation. When combined with other advances in crop sciences, CRISPR could increase crop productivity in a “sustainable intensification” mode on the 1.5 billion hectares of global arable land, and make a vital contribution to global food security.
For more information and other details about the 2015 report, visit www.isaaa.org.

Friday, March 13, 2015

Global Status of Commercialized Biotech/GM Crops 2014 Launched in Beijing; Media Conferences Held in Asian Countries

Since 1996, during the first year of commercialization of biotech crops, ISAAA has released the annual “Global Status of Commercialized Biotech/GM Crops” (ISAAA Brief No. 49), a Report that documents the latest information on the global status of commercially approved biotech crops. Year after year, ISAAA prepares the Report and supports its free distribution to developing countries to provide information and knowledge to the scientific community and facilitate a more informed and transparent discussion regarding the potential role of biotech crops in contributing to global food, feed, fiber, and fuel security, and a more sustainable agriculture.

The 2014 Global Status Report is the 19th Brief in the series, and documents the global database on the adoption and distribution of biotech crops in the world in 2014, when 18 million farmers from 28 countries planted 181.5 million hectares of biotech crops. Below are summaries of the country launches held for the 2014 Global Status Report.


BEIJING, CHINA

Brief 49 was launched at the China World Hotel in Beijing, China on January 28, 2015, with 35 media representatives. A seminar where Dr. Clive James presented the global status of commercialized biotech/GM crops in 2014 was held at the Chinese Academy of Agricultural Sciences (CAAS) on January 29, and co-organized by CAAS, ISAAA, China BIC, and five professional societies in China. The seminar was attended by 200 stakeholders from the government, academe, research institutes, media agencies, and private companies. Guests during the seminar include Dr. Chen Zhangliang, Vice President of China Association for Science and Technology (CAST), Dr. Paul Teng, and Dr. Randy Hautea.
Dr. James presenting the global status of commercialized biotech/GM crops during the seminar in Beijing, China.

SEOUL, SOUTH KOREA

In Seoul, the media seminar for Brief 49 was held at The Plaza Hotel on January 30. It was attended by more than 60 people from the government, academe, and private companies. Dr. James presented the global status of commercialized biotech/GM crops in 2014. The seminar was co-organized by Dr. Soo-Chul Park, director of the National Center for GM Crops (NCGC) of the Next-Generation BioGreen21 Program in RDA, South Korea; and Dr. Tae-San Kim, director of CropLife Asia.

Dr. Park emphasized the need for the development of GM crops in Korea and mentioned 4 events (drought tolerant rice, herbicide-resistant/male sterility grass, virus resistant red pepper) that are under risk assessment.
More than 60 people from the government, academe, and private companies attended the seminar in Seoul.

TOKYO, JAPAN

The seminar and media engagement in Tokyo were facilitated by Dr. Fusao Tomita, the Nippon BIC director and the Council for Biotechnology Information in Japan (CBIJ) currently headed by Dr. Masahiro Suzuki. The event was held at Belle Salle Yaesu on February 2 and gathered more than 100 participants composed of media, policy makers, and the academe, an impossible feat on a Monday in Japan. Dr. Suzuki opened the seminar and provided information on the activities of CBIJ, followed by the presentations of Dr. James and Dr. Hautea. Dr. Tomita presented the current status and views of GM crops in Japan. A short meeting with the media was also held immediately after the seminar.
Dr. James at the media seminar in Tokyo.

HANOI, VIETNAM

Brief 49 was presented at a conference held at the Sofitel Hotel in Hanoi, on February 3. Hosted by the Ministry of Agriculture and Rural Development, Vietnam Academy of Agricultural Sciences, and AgBiotech Vietnam, in cooperation with ISAAA, the conference was attended by more than 100 regulators and scientists from science, environment and agriculture ministries, members of the academe and research institutes, representatives of businesses, associations and media agencies.

Dr. James presented the global status of biotech/GM crops. Dr. Hautea discussed the application and benefits of biotech corn in the Philippines, while Dr. Mahaletchumy Arujanan, Executive Director of Malaysian Biotechnology Information Centre (MABIC) highlighted the role of the media in providing correct and objective information about biotech crops against the misconception of this technology.

Heads of ministries graced the occasion, including Dr. Nguyen Thi Thanh Thuy,  General Director of Department of Science and Technology of the Ministry of Agriculture and Rural Development; and Prof. Dr. Trinh Khac Quang, Director of the Vietnam Academy of Agricultural Sciences. Discussions on the Q and A revolved around management of biotech seeds after commercialization and effective methods of communication on biotech crops to the public.
Dr. James is joined by Dr. Le Huy Ham (left) and Dr. Vo Tung Xuan (right) during the seminar in Hanoi.  

BANGKOK, THAILAND

Thailand’s Biosafety and Biotechnology Information Center (BBIC) Director Dr. Supat Attathom and Biotechnology Alliance Association (BAA) head Dr. Nipon Lamsupasit led the seminar in Bangkok held in Century Park Hotel on February 4. 119 participants composed of media, policy makers, the academe, and the industry attended the seminar. Simultaneous translation during the seminar was supported by BAA.

The seminar which featured presentations from Drs. James, Hautea, and Arujanan  was opened by Prof. Dr. Yongyuth Yuthawong, the Deputy Prime Minister of Thailand, who also met with the ISAAA team at breakfast. The country has permitted field trials of GM crops and is looking forward to commercialization. Former agriculture minister Thira Sutabutra also attended the seminar.
Dr. Hautea and Dr. James is joined by Dr. Arujanan in Bangkok.

YANGON & NAY PYI TAW, MYANMAR

Myanmar Ministry of Agriculture and Irrigation (MOAI), the National Economic and Social Advisory Council (NESAC) co-organized the ISAAA seminars held in Summer Park View Hotel, Yangon on February 5; and at Thingaha Hotel, Nay Pyi Taw on February 6.

At the Yangon media conference, Dr. Sein Hla Bo, Presidential Economic Advisor to the President of the Republic of the Union of Myanmar chaired the seminar. More than 30 media representatives and members of the academe in Yangon attended the briefings by Dr. James and Mr. Bhagirath Choudhary, ISAAA Director for Strategic Initiatives.

The Nay Pyi Taw seminar was attended by more than 50 government representatives, policy makers, members of the academe, and media representatives. Dr. Ye Tint Htun, Director General of Department of Agriculture presided over the seminar with presentations from Dr. James, Mr. Choudhary, as well as from Dr. Khin Thida Myint, professor at Yezin Agricultural University who discussed the progress of GM crops in Myanmar, and the possibility of developing collaborative project on other crops important to food security in Myanmar. Prof. Daw Than Than Nu of the Department of Industrial Crops Development shared the achievement of Bt cotton and the development of new promising Bt cotton variety Ngwe Chi-9, to be released in the near future. It was notable that Dr. Ye Tint Htun, Director General of Department of Agricultural Research of the MOAI invited ISAAA to help them access new biotechnologies and facilitate technology transfer to Myanmar.
Dr. James (center) and Mr. Choudhary (second from left) at the seminar in Yangon.

DHAKA, BANGLADESH

Dr. James was joined by the Honorable Minister of Agriculture Matia Chowdhury who gave a message in the seminar in Dhaka held at the Bangladesh Agricultural Council (BARC) on February 8.

The event was co-organized by Bangladesh Biotechnology Information Center (BdBIC) Director Prof. Dr. Khondoker Nasiruddin and ISAAA in partnership with BARC and ABSP II (Agricultural Biotechnology Support Project II). Dr. James and Mr. Choudhary were joined in the forum by Dr. Md Rafiqual Islam Modal, Director General of BARI; Prof. Dr. Md Shahidur Rashid Bhuiyan, Pro VC of Sher-e-Bangla Agricultural University; Dr. Abul Kalam Azad, Executive Chairman BARC; Prof. Md Shadat Ullah, VC of Sher-e-Bangla Agricultural University and Mr. Md Eunusur Rahman, Secretary of Agriculture who each gave short message during the program. Around 450 participants from the scientific community, agricultural universities, different government departments, industry, seven media outlets who recorded the event, and a dozen print and online media attended the seminar.
Hon. Minister for Agriculture Matia Chowdhury was chief guest during the launch in Dhaka.

JAKARTA, INDONESIA

The seminar in Indonesia was attended by 150 stakeholders consisting of scientists, academicians, policy makers, farmers, journalists, and entrepreneurs. It was held on February 11, 2015. Dr. James shared the recent global developments in biotechnology. It was organized by the Indonesian Biotechnology Information Center (IndoBIC), ISAAA, Ministry of Agriculture, and National Outstanding Farmers Association (NOFA), and supported by the Indonesian Society for Agricultural Biotechnology (PBPI), CropLife Indonesia, and SEAMEO BIOTROP.

Dr. James also highlighted a significant development in biotechnology in Asia, saying that Vietnam and Indonesia are close to the commercialization of biotech crops, which is expected to begin in 2015. Dr. Ir. Hasil Sembiring, General Director of Food Crops of the Ministry of Agriculture represented the Minister to deliver the opening remarks on that event.
Speakers and moderator of the seminar in Jakarta (left to right): Prof. Agus Pakpahan, Dr. Hautea, Dr. Teng, Dr. James, and Ms. Veronica Moniaga.

MANILA, PHILIPPINES

The Manila launch of Brief 49 highlighted the continued expansion of biotech corn in the country. A media conference, co-organized with the Southeast Asian Regional Center for Graduate Study and Research in Agriculture (SEARCA), was held on February 27, at the InterContinental Manila Hotel in Makati City. 

Speakers at the conference include ISAAA Board Chair Dr. Paul S. Teng; Dr. Hautea; ISAAA Senior Program Officer Dr. Rhodora R. Aldemita who presented the global status of commercialized biotech/GM crops in 2014; and Bukidnon farmer Mr. Edgar Talasan, who expressed his eagerness to plant an upcoming biotech crop, Bt eggplant. Representatives from government offices, scientists, and members of the media attended the seminar.
ISAAA Senior Program Officer Dr. Rhodora R. Aldemita presented the global status of commercialized biotech/GM crops in 2014 during the seminar in Manila.


More information about ISAAA's Global Status of Commercialized Biotech/GM Crops: 2014 are available at ISAAA website: http://www.isaaa.org/resources/publications/briefs/49/default.asp. Various information resources, including the Executive Summary, Top Ten Facts about Biotech/GM Crops in 2014, Powerpoint slides, infographics, and videos are all available for download from the same link.

For more information about ISAAA, visit http://www.isaaa.org/, or follow ISAAA on Facebook (https://www.facebook.com/isaaa.org) and Twitter (https://twitter.com/isaaa_org).

Thursday, January 29, 2015

Biotech Crops Show Sustained Growth and Benefits in 2014; Global Plantings Increase by 6 Million Hectares

The 2014 Global Status of Commercialized Biotech/GM Crops, authored by Clive James, Founder and Emeritus Chair of ISAAA, reports that a record 181.5 million hectares of biotech crops were grown globally, an increase of more than 6 million hectares from 2013. With the addition of Bangladesh, 28 countries grew biotech crops during the year. The 20 developing and eight industrial countries where biotech crops are planted represent more than 60 percent of the world’s population.

“The accumulated hectarage of biotech crops grown in 1996 to 2014 equals, roughly, 80 percent more than the total land mass of China. Global hectarage has increased more than 100-fold since the first plantings of biotech crops.” - Clive James

Since 1996, more than 10 food and fiber biotech crops have been approved and commercialized around the world. These range from major commodities such as maize, soybean and cotton, to fruits and vegetables like papaya, eggplant and, most recently, potato. The traits of these crops address common issues affecting crop benefits to the consumer and production rates for farmers, including drought tolerance, insect and disease resistance, herbicide tolerance and increased nutrition and food quality. Biotech crops contribute to more sustainable crop production systems and provide resilient responses to the challenges of climate change.

According to the Report, the United States continues to lead production at 73.1 million hectares, up 3 million hectares from 2013, the highest year-over-year increase, surpassing Brazil, which has recorded the highest annual increase for the past five years.


The Report also highlighted key benefits of biotechnology, including alleviation of poverty and hunger by boosting the income of risk-averse small, resource-poor farmers around the world. Latest global provisional information for the period 1996 to 2013 shows that biotech crops increased production valued at US$133 billion; in the period 1996 to 2012 pesticide use decreased significantly saving approximately 500 million kg of active ingredient. In 2013 alone, crop plantings lowered carbon dioxide emissions equivalent to removing 12.4 million cars from the road for one year.

These findings are consistent with a rigorous meta-analysis, conducted by economists Wilhelm Klumper and Matin Qaim in November 2014, which concludes that GM technology has, on average, reduced chemical pesticide use by 37 percent, increased crop yields by 22 percent, and increased farmer profits by 68 percent during the 20-year period 1995 to 2014. 

A corn farmer's family in the Philippines (ISAAA file photo)

Bangladesh: a model for success

Bangladesh, one of the smallest and poverty-stricken countries in the world, approved Bt brinjal (eggplant) in October 2013. Commercial planting began in January 2014 when 120 farmers planted 12 hectares of Bt brinjal throughout the year. Bt brinjal not only brings financial opportunity to farmers in the country, but also decreases farmer exposure to pesticides by 70 to 90 percent.

“The timely approval and commercialization of Bt brinjal in Bangladesh speaks to the power of political will and support from the government. This lays the foundation as a model of success for other small, poor countries to quickly introduce the benefits of biotech crops.”

The case of Bangladesh in 2014 reconfirms the value and success of public-private partnerships. The Bt biotech trait for brinjal – one of the most nutritious and important vegetables in Bangladesh – was donated by Mahyco, an Indian company.

“Public-private partnerships continue to increase the probability of timely delivery of approved biotech crops at the farm level,” James said. “They will remain essential in the years to come.”

The Water Efficient Maize for Africa (WEMA) Project is another example of a public-private partnership at work. Beginning in 2017, select African countries are scheduled to receive the first biotech drought tolerant maize, a food staple for more than 300 million Africans. The donated biotechnology trait is the same as the DroughtGard™ variety used in the United States, which increased 5.5-fold in planted hectares from 2013 to 2014. This demonstrates strong farmer acceptance of the biotech drought tolerant maize.

New approvals address consumer concerns

In the United States, approval of the Innate™ potato was granted in November 2014. The Innate potato decreases production of acrylamide, a potential carcinogen, when potatoes are cooked at high temperatures. Furthermore, it increases consumer satisfaction while precluding up to 40 percent yield loss as the potato will not discolor when peeled and has fewer bruising spots. These attributes will have meaningful impact on food security as food waste continues as an important factor in the discussion of feeding 9.6 billion people in 2050 and approximately 11 billion in 2100.

Potatoes represent the fourth most important food staple in the world. As such, a continuous effort is being made to improve the potato and combat losses due to diseases, insects and weeds, and other constraints.

Biotech-based control of the fungal disease late-blight, the most important disease of potatoes in the world, is already being field-tested in Bangladesh, India and Indonesia. Late-blight caused the 1845 Irish famine, which resulted in 1 million deaths. Biotech control of virus diseases and the Colorado beetle, the most important insect pest, are already available, but not deployed.

Status of biotech crops in Asia

In Asia, China and India continue to lead developing countries growing biotech crops at 3.9 million hectares and 11.6 million hectares planted in 2014, respectively.

The adoption rate of biotech cotton in China increased from 90 to 93 percent in 2014, while virus resistant papaya plantings increased approximately 50 percent. More than 7 million small farmers in the country continue to benefit from biotech crops and the latest economic data available indicates farmers in the country have gained US$16.2 billion since the introduction of biotech in 1996.

Bt cotton farmer in China (ISAAA file photo)

According to the Report, India cultivated a record 11.6 million hectares of Bt cotton with an adoption rate of 95 percent. Economists Brookes and Barfoot estimate that India enhanced farm income from Bt cotton by US$ 2.1 billion in 2013 alone.

Farmers at a cotton farm in India (ISAAA file photo)

Developing countries Vietnam and Indonesia granted approval for commercialization of biotech crops to begin in 2015. This includes several hybrids of biotech maize for importing and planting in Vietnam and drought tolerant sugarcane for planting as a food crop in Indonesia. 
  
Growth continues in Africa and Latin America

Having cultivated 2.7 million hectares in 2014, South Africa ranks as the leading developing country to grow biotech crops in Africa. Sudan increased Bt cotton hectarage by approximately 50 percent in 2014 and several African countries including Cameroon, Egypt, Ghana, Kenya, Malawi, Nigeria and Uganda conducted field trials on several pro-poor crops including the food crops rice, maize, wheat, sorghum, bananas, cassava and sweet potato. These crops can contribute to resilience and sustainability in the face of new climate change challenges.

In Latin America, Brazil ranked second, after the United States, for biotech crops planted in 2014. At 42.2 million hectares, this represents an increase of 5 percent from 2013.

Biotech crops impact food security, sustainability and the environment

From 1996 to 2013, biotech crops have increased crop production valued provisionally at $US133 billion; helped alleviate poverty for more than 16.5 million small farmers and their families – more than 65 million people, collectively – some of the poorest people in the world; and decreased the environmental impact of food and fiber production by reducing pesticide use, increasing land savings and reducing CO2 emissions.

According to economists Graham Brookes and Peter Barfoot, if the 441 million tons of food, feed and fiber from biotech crops from 1996 to 2013 were not produced, an additional 132 million hectares of conventional crops would be needed to produce the same tonnage. This required increase in hectares could have negative impacts for biodiversity and the environment due to a greater demand for cultivated land.


The International Service for the Acquisition of Agri-biotech Applications (ISAAA) is a not-for-profit organization with an international network of centers designed to contribute to the alleviation of hunger and poverty by sharing knowledge and crop biotechnology applications. Clive James, Emeritus Chairman and Founder of ISAAA, has lived and/or worked for the past 30 years in the developing countries of Asia, Latin America and Africa, devoting his efforts to agricultural research and development issues with a focus on crop biotechnology and global food security.


For more information about ISAAA and Brief 49, visit http://www.isaaa.org.


The Top 10 Facts, infographics, and PowerPoint slides are available at: http://www.isaaa.org/resources/publications/briefs/49/default.asp.



Monday, April 21, 2014

ISAAA Brief 46 Publications, Videos



ISAAA's Brief 46, Global Status of Commercialized Biotech/GM Crops in 2013, written by ISAAA founder and emeritus chair Dr. Clive James, has reached over 3.7 billion media impressions 2 months after its global launch. The number of media articles has increased to 2,231 in the same period of time, with Brief 46 materials translated into 45 major languages, reaching 72 countries worldwide.

The two-page highlights of the full Brief 46, "Top Ten Facts on Global Biotech/GM Crops in 2013 has been translated and now available in 53 languages. The languages are: Amharic, Arabic, Bahasa, Balochi, Bangla, Bicolano, Bisaya, Brahvi, Bulgarian, Burmese, Chichewa, Chinese, Chitumbuka, Czech, Danish, Dutch, English, Ewe, Farsi, Filipino, Finnish, French, German, Hausa, Hindi, Hungarian, Igbo, Ilokano, Japanese, Kabyè, Khmer, Korean, Luganda, Malay, Pashto, Polish, Portuguese, Punjabi, Romanian, Russian, Sindhi, Siraiki, Slovak, Spanish, Swahili, Swedish, Thai, Turkish, Ukrainian, Urdu, Vietnamese, Welsh, and Yoruba. The translations are available for download at: http://bit.ly/1gCIRmS.

The Executive Summary, a 13-page document summarizing information on hectarage, adoption, and benefits of biotech crops in 2013, as well as its future prospects, is now available in 12 languages: Arabic, Balochi, Brahvi, Chinese, English, Farsi, French, Portuguese, Russian, Spanish, Swahili, and Ukrainian. The translations are available for download at: http://bit.ly/1j7TcIV. 




ISAAA Brief 46 is also summarized and presented in four videos: 


More information about ISAAA's Global Status of Commercialized Biotech/GM Crops: 2013 are available at ISAAA's website at http://www.isaaa.org/resources/publications/briefs/46/default.asp. Various information resources, including the Executive Summary and its translations, Top Ten Facts about Biotech/GM Crops in 2013, Powerpoint Slides, Infographics, and videos are all available for download from the same link.

For more information about ISAAA, visit http://www.isaaa.org/, or follow ISAAA on Facebook (https://www.facebook.com/isaaa.org) and Twitter (https://twitter.com/isaaa_org).

Sunday, March 16, 2014

Global Status of Commercialized Biotech/GM Crops 2013 Seminars in Indonesia, Bangladesh, and Philippines

A month after the international launch of ISAAA's 2013 Global Status of Commercialized Biotech/GM Crops in Beijing, 10 countries in Asia have held their respective launches and media seminars. ISAAA's monitoring of the tri-media shows that one month after the international launch, Brief 46 has been mentioned in 1,933 news articles and 1,777 social media posts in 77 countries with a total impression data of 2,147,275,067.

Our previous blog posts discussed the country launches in China, South Korea, Japan, Vietnam, Thailand, and Myanmar. The following are summaries of the events in Indonesia, Bangladesh, and the Philippines.


BANGLADESH

In Bangladesh, the seminar/launch for ISAAA Brief 46 was held in Dhaka, Bangladesh on February 26. The event was highlighted by the keynote speech of Agriculture Minister Matia Chowdhury. Minister Chowdhury said that "Being an overpopulated country, we will not hesitate in using biotechnology if it is proven to be useful and safe for human, animal and for the environment." She urged scientists to develop new crop varieties through frontier research using biotechnology to combat the environmental hazards like salinity, drought, submergence, and cold.

Bangladesh Biotechnology Information Centre (BdBIC) and ISAAA, in collaboration with the Bangladesh Agricultural Research Council (BARC) and Bangladesh Agricultural Research Institute (BARI) organized the seminar which was attended by around 350 policy planners, academicians, researchers, extension officers, research students, and journalists.

Dr. James (third from left) is joined by Minister Chowdhury during the launch of Brief 46 in Dhaka.

INDONESIA

The Jakarta, Indonesia seminar was held on February 28, and was attended by 128 people. Dr. Mahaletchumy Arujanan of Malaysia BIC joined Dr. Clive James and Dr. Randy Hautea by giving a presentation "Communicating Agri-biotech: Scientific Accuracy vs Popularized Myths." Two interviews for release on television were conducted featuring Dr. Clive James.

Drs. James and Hautea was joined by Dr. Arujanan during the launch in Jakarta.

PHILIPPINES

A media conference was held on March 6, 2014 at Dusit Thani Hotel, Makati City, with more than 60 people in attendance, composed of multi-media journalists, members of the academe, government agencies, private sector, non-government organizations, and local government units. At the conference, ISAAA Chair Dr. Paul Teng talked about food security and how biotech crops help contribute in various aspects of food security, such as improvement of nutrition and agricultural productivity. ISAAA Global Coordinator and SEAsiaCenter Director Dr. Randy Hautea presented the global status, trends, and significant benefits of biotech crop adoption.

Resource persons of the media conference in Makati are (Left to right): DA Undersecretary Segfredo Serrano, ISAAA Global Coordinator and SEAsia Center Director Dr. Hautea, ISAAA Chair Dr. Teng, SEARCA Director Dr. Gil Saguiguit, and Former University of the Philippines President and UPLB Chancellor Dr. Emil Q. Javier.

More information about ISAAA's Global Status of Commercialized Biotech/GM Crops: 2013 are available at ISAAA's website at http://www.isaaa.org/resources/publications/briefs/46/default.asp. Various information resources, including the Executive Summary, Top Ten Facts about Biotech/GM Crops in 2013, Powerpoint Slides, Infographics, and videos are all available for download from the same link.

For more information about ISAAA, visit http://www.isaaa.org/, or follow ISAAA on Facebook (https://www.facebook.com/isaaa.org) and Twitter (https://twitter.com/isaaa_org).